Developments in FGFR and IDH inhibitors for cholangiocarcinoma therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Developments in FGFR and IDH inhibitors for cholangiocarcinoma therapy

Published:2023-02-09 Issue:3 Volume:23 Page:257-264
ISSN:1473-7140
Container-title:Expert Review of Anticancer Therapy
language:en
Short-container-title:Expert Review of Anticancer Therapy

Author:

Brown Zachary J¹,Ruff Samantha M.²,Pawlik Timothy M²

Affiliation:

1. Department of Surgery, Summit Health, Berkeley Heights, NJ, USA

2. Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, USA

Funder

funding

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737140.2023.2176846

Reference60 articles.

1. Cholangiocarcinoma: Current Knowledge and New Developments

2. Increased multimodality treatment options has improved survival for Hepatocellular carcinoma but poor survival for biliary tract cancers remains unchanged

3. Epidemiology of Cholangiocarcinoma; United States Incidence and Mortality Trends

4. Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ETV4 promotes the progression of cholangiocarcinoma by regulating glycolysis via the TGF-β signaling;Translational Oncology;2024-09

2. Exploring Molecular Mechanisms in the Second-Line Treatment of Biliary Tract Malignant Tumors;Discovery Medicine;2024

3. Surgical management of intrahepatic cholangiocarcinoma;Hepatoma Research;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP